Cargando…
Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study
INTRODUCTION: Metformin may provide a therapeutic benefit in different types of malignancy. PURPOSE: We aimed at evaluating the effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopaus...
Autores principales: | El-attar, Aya Ahmed, Ibrahim, Osama Mohamed, Alhassanin, Suzan Ahmed, Essa, Enas Said, Mostafa, Tarek Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879830/ https://www.ncbi.nlm.nih.gov/pubmed/36562831 http://dx.doi.org/10.1007/s00228-022-03444-6 |
Ejemplares similares
-
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
por: Kim, Jisun, et al.
Publicado: (2014) -
Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment
por: Jung, Yongsik, et al.
Publicado: (2018) -
Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review
por: Monnier, Alain
Publicado: (2009) -
Stereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats
por: Noorafshan, Ali, et al.
Publicado: (2013) -
Obesity and outcome of post-menopausal women receiving adjuvant letrozole for breast cancer
por: Zekri, Jamal, et al.
Publicado: (2018)